Bank of Nova Scotia’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331M Buy
360,137
+15,854
+5% +$16.1M 0.58% 27
2025
Q4
$370M Buy
344,283
+10,979
+3% +$10.5M 0.55% 28
2025
Q3
$254M Buy
333,304
+85,044
+34% +$63.3M 0.45% 37
2025
Q2
$194M Buy
248,260
+1,376
+0.6% +$1.07M 0.4% 40
2025
Q1
$204M Sell
246,884
-119,523
-33% -$99.5M 0.46% 41
2024
Q4
$283M Buy
366,407
+177,831
+94% +$147M 0.49% 33
2024
Q3
$167M Sell
188,576
-49,918
-21% -$44.9M 0.34% 51
2024
Q2
$216M Buy
238,494
+58,240
+32% +$46.6M 0.42% 39
2024
Q1
$140M Sell
180,254
-320,173
-64% -$228M 0.28% 64
2023
Q4
$292M Buy
500,427
+228,341
+84% +$133M 0.55% 38
2023
Q3
$146M Buy
272,086
+28,228
+12% +$14.5M 0.39% 52
2023
Q2
$114M Buy
243,858
+143,628
+143% +$60.2M 0.3% 64
2023
Q1
$34.4M Sell
100,230
-98,893
-50% -$33.4M 0.1% 152
2022
Q4
$72.8M Buy
199,123
+42,924
+27% +$15.2M 0.19% 99
2022
Q3
$50.5M Sell
156,199
-39,367
-20% -$12.5M 0.16% 109
2022
Q2
$63.4M Sell
195,566
-196,487
-50% -$59M 0.15% 124
2022
Q1
$112M Buy
392,053
+223,466
+133% +$57.5M 0.19% 106
2021
Q4
$46.6M Buy
168,587
+26,674
+19% +$6.76M 0.07% 251
2021
Q3
$32.8M Buy
141,913
+8,735
+7% +$2.16M 0.06% 275
2021
Q2
$30.6M Sell
133,178
-113,832
-46% -$22.9M 0.06% 251
2021
Q1
$46.1M Sell
247,010
-28,369
-10% -$5.55M 0.09% 179
2020
Q4
$46.5M Sell
275,379
-800,814
-74% -$120M 0.1% 181
2020
Q3
$159M Buy
1,076,193
+589,125
+121% +$91.2M 0.43% 59
2020
Q2
$80M Sell
487,068
-231,248
-32% -$35.5M 0.28% 83
2020
Q1
$99.6M Sell
718,316
-315,780
-31% -$43.4M 0.34% 70
2019
Q4
$136M Buy
1,034,096
+73,653
+8% +$8.54M 0.33% 76
2019
Q3
$107M Buy
960,443
+258,907
+37% +$28.8M 0.32% 78
2019
Q2
$76.8M Buy
701,536
+103,286
+17% +$12.2M 0.32% 71
2019
Q1
$77.6M Buy
598,250
+36,536
+7% +$4.44M 0.31% 74
2018
Q4
$65M Buy
561,714
+262,941
+88% +$29.4M 0.3% 78
2018
Q3
$32M Buy
298,773
+89,829
+43% +$8.98M 0.14% 137
2018
Q2
$17.8M Sell
208,944
-42,094
-17% -$3.46M 0.1% 164
2018
Q1
$19.4M Sell
251,038
-258,973
-51% -$20.8M 0.1% 191
2017
Q4
$43.1M Buy
510,011
+338,961
+198% +$28.8M 0.2% 119
2017
Q3
$14.6M Sell
171,050
-50,587
-23% -$4.15M 0.09% 201
2017
Q2
$18.2M Sell
221,637
-3,194
-1% -$261K 0.1% 188
2017
Q1
$18.9M Buy
224,831
+202,758
+919% +$16.2M 0.08% 195
2016
Q4
$1.62M Sell
22,073
-97,686
-82% -$7.27M 0.01% 415
2016
Q3
$9.61M Buy
119,759
+100,310
+516% +$8.03M 0.05% 169
2016
Q2
$1.53M Sell
19,449
-9,212
-32% -$694K 0.01% 321
2016
Q1
$2.06M Buy
28,661
+3,660
+15% +$277K 0.01% 294
2015
Q4
$2.11M Sell
25,001
-5,221
-17% -$433K 0.01% 334
2015
Q3
$2.52M Buy
30,222
+3,392
+13% +$286K 0.01% 247
2015
Q2
$2.24M Buy
26,830
+778
+3% +$59.3K 0.01% 223
2015
Q1
$1.89M Sell
26,052
-13,970
-35% -$995K 0.01% 236
2014
Q4
$2.76M Sell
40,022
-7,404
-16% -$500K 0.01% 212
2014
Q3
$3.08M Sell
47,426
-20,708
-30% -$1.31M 0.01% 205
2014
Q2
$4.24M Sell
68,134
-13,648
-17% -$814K 0.02% 193
2014
Q1
$4.81M Sell
81,782
-142,977
-64% -$7.98M 0.02% 209
2013
Q4
$11.5M Buy
224,759
+89,360
+66% +$4.47M 0.05% 154
2013
Q3
$6.82M Sell
135,399
-32,626
-19% -$1.71M 0.03% 144
2013
Q2
$8.25M Buy
+168,025
New +$9.14M 0.04% 139

Other funds holding LLY

Bank of Nova Scotia's LLY Position: Q1 2026 in Review

Bank of Nova Scotia increased its Eli Lilly (LLY) stake by 4.6% in Q1 2026, buying an estimated $16.1M and bringing the position to 360,137 shares worth $331M. The position accounts for 0.58% of the portfolio, ranked #27.

Bank of Nova Scotia first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $370M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bank of Nova Scotia held 360,137 shares of Eli Lilly worth $331M as of Q1 2026.
  • Bank of Nova Scotia bought 15,854 Eli Lilly shares in Q1 2026, an estimated $16.1M.
  • Eli Lilly made up 0.58% of Bank of Nova Scotia's portfolio in Q1 2026, its #27 holding.
  • Bank of Nova Scotia first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Eli Lilly position peaked at $370M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.